-transparent.png){kind=logo}
The haemodynamic response and pharmacokinetics of single dose oral tolmesoxide were studied at various dose levels in 4 patients with severe hypertension. There was a reproducible fall in mean arterial pressure from baseline of 24.2% and a rise in heart rate of 37.6% following administration of tolmesoxide. The onset of antihypertensive action occurred within 1 h, with a peak effect at 3 h after dosing. The mean duration of action was up to 12.0 h. Tolmesoxide had a mean half-life of 3.0 h. It was rapidly absorbed with a mean peak plasma level occurring at 1.0 h. Plasma levels correlated well with the doses administered. Side-effects include mild nausea, facial flushing and postural symptoms.
C P O'Boyle, and
M Laher, and
E T O'Brien, and
K O'Malley, and
J G Kelly
January 1977,
Acta cientifica venezolana,
C P O'Boyle, and
M Laher, and
E T O'Brien, and
K O'Malley, and
J G Kelly
January 1980,
Archives internationales de pharmacodynamie et de therapie,
C P O'Boyle, and
M Laher, and
E T O'Brien, and
K O'Malley, and
J G Kelly
July 1990,
Ceskoslovenska farmacie,
C P O'Boyle, and
M Laher, and
E T O'Brien, and
K O'Malley, and
J G Kelly
April 1980,
The Medical journal of Australia,
C P O'Boyle, and
M Laher, and
E T O'Brien, and
K O'Malley, and
J G Kelly
March 1980,
The New Zealand medical journal,
C P O'Boyle, and
M Laher, and
E T O'Brien, and
K O'Malley, and
J G Kelly
January 1982,
European journal of clinical pharmacology,
C P O'Boyle, and
M Laher, and
E T O'Brien, and
K O'Malley, and
J G Kelly
August 1997,
Journal of human hypertension,
C P O'Boyle, and
M Laher, and
E T O'Brien, and
K O'Malley, and
J G Kelly
January 1981,
European journal of clinical pharmacology,
C P O'Boyle, and
M Laher, and
E T O'Brien, and
K O'Malley, and
J G Kelly
October 1968,
Praxis,
C P O'Boyle, and
M Laher, and
E T O'Brien, and
K O'Malley, and
J G Kelly
May 1969,
La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
